Autonomix Medical (AMIX) Competitors $13.36 +0.17 (+1.29%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrends AMIX vs. APT, LUCD, NTRB, APYX, CTSO, NXL, CLGN, MLSS, BLAC, and COCHShould you be buying Autonomix Medical stock or one of its competitors? The main competitors of Autonomix Medical include Alpha Pro Tech (APT), Lucid Diagnostics (LUCD), Nutriband (NTRB), Apyx Medical (APYX), Cytosorbents (CTSO), Nexalin Technology (NXL), CollPlant Biotechnologies (CLGN), Milestone Scientific (MLSS), Bellevue Life Sciences Acquisition (BLAC), and Envoy Medical (COCH). These companies are all part of the "medical equipment" industry. Autonomix Medical vs. Alpha Pro Tech Lucid Diagnostics Nutriband Apyx Medical Cytosorbents Nexalin Technology CollPlant Biotechnologies Milestone Scientific Bellevue Life Sciences Acquisition Envoy Medical Alpha Pro Tech (NYSE:APT) and Autonomix Medical (NASDAQ:AMIX) are both small-cap industrial products companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, community ranking, earnings, institutional ownership, media sentiment and dividends. Do insiders & institutionals believe in APT or AMIX? 22.7% of Alpha Pro Tech shares are held by institutional investors. Comparatively, 10.8% of Autonomix Medical shares are held by institutional investors. 14.0% of Alpha Pro Tech shares are held by insiders. Comparatively, 32.4% of Autonomix Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Does the media prefer APT or AMIX? In the previous week, Alpha Pro Tech's average media sentiment score of 0.84 beat Autonomix Medical's score of 0.00 indicating that Alpha Pro Tech is being referred to more favorably in the media. Company Overall Sentiment Alpha Pro Tech Positive Autonomix Medical Neutral Does the MarketBeat Community favor APT or AMIX? Alpha Pro Tech received 15 more outperform votes than Autonomix Medical when rated by MarketBeat users. CompanyUnderperformOutperformAlpha Pro TechOutperform Votes16100.00% Underperform VotesNo VotesAutonomix MedicalOutperform Votes1100.00% Underperform VotesNo Votes Is APT or AMIX more profitable? Alpha Pro Tech has a net margin of 6.99% compared to Autonomix Medical's net margin of 0.00%. Alpha Pro Tech's return on equity of 6.70% beat Autonomix Medical's return on equity.Company Net Margins Return on Equity Return on Assets Alpha Pro Tech6.99% 6.70% 5.76% Autonomix Medical N/A -542.11%-236.92% Do analysts rate APT or AMIX? Autonomix Medical has a consensus price target of $28.00, suggesting a potential upside of 109.58%. Given Autonomix Medical's stronger consensus rating and higher probable upside, analysts plainly believe Autonomix Medical is more favorable than Alpha Pro Tech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Alpha Pro Tech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Autonomix Medical 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has higher valuation and earnings, APT or AMIX? Alpha Pro Tech has higher revenue and earnings than Autonomix Medical. Autonomix Medical is trading at a lower price-to-earnings ratio than Alpha Pro Tech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlpha Pro Tech$59.29M0.98$4.19M$0.3714.28Autonomix MedicalN/AN/A-$15.43M-$16.07-0.83 SummaryAlpha Pro Tech beats Autonomix Medical on 10 of the 14 factors compared between the two stocks. Ad DTIWhen it comes to NVDA… “acceleration cycles” are the keyExpert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.Use this link to see Nvidia Unchained right away! Get Autonomix Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for AMIX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AMIX vs. The Competition Export to ExcelMetricAutonomix MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$15.36M$4.42B$5.06B$8.82BDividend YieldN/A41.17%5.18%4.07%P/E Ratio-0.8324.81126.3217.81Price / SalesN/A47.011,179.2574.56Price / CashN/A51.8733.8632.53Price / Book1.654.974.684.68Net Income-$15.43M$13.76M$119.54M$226.08M7 Day Performance39.60%-1.08%-1.83%-1.04%1 Month Performance29.46%0.58%-3.60%1.04%1 Year PerformanceN/A50.91%31.91%26.28% Autonomix Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AMIXAutonomix Medical2.2386 of 5 stars$13.36+1.3%$28.00+109.6%N/A$15.36MN/A-0.831APTAlpha Pro TechN/A$5.29-1.1%N/A+11.1%$58.13M$59.29M14.28120LUCDLucid Diagnostics3.2198 of 5 stars$1.00+4.2%$3.69+268.8%-23.1%$56.72M$2.43M0.0070NTRBNutriband0.6276 of 5 stars$4.98+1.4%N/A+125.3%$54.53M$2.09M0.0010APYXApyx Medical1.4466 of 5 stars$1.40+9.4%N/A-39.1%$52.70M$48.54M-1.58270CTSOCytosorbents1.2772 of 5 stars$0.92-4.2%$2.00+118.4%-34.6%$52.47M$33.79M-2.54186Analyst ForecastGap DownNXLNexalin Technology0.7353 of 5 stars$3.80-2.1%$3.00-21.1%+1,051.5%$49.90M$110,000.000.003CLGNCollPlant Biotechnologies1.8582 of 5 stars$4.23+1.0%$11.00+160.0%-24.2%$48.43M$10.96M-2.7570Upcoming EarningsMLSSMilestone Scientific2.1701 of 5 stars$0.68+9.7%$1.25+84.4%-15.8%$48.30M$9.83M0.0030Analyst ForecastBLACBellevue Life Sciences AcquisitionN/A$11.60-0.6%N/A+11.0%$46.86MN/A0.00N/ACOCHEnvoy Medical3.0553 of 5 stars$2.15+5.4%$7.92+268.2%+115.0%$42.14M$320,000.000.0034Gap Up Related Companies and Tools Related Companies Alpha Pro Tech Competitors Lucid Diagnostics Competitors Nutriband Competitors Apyx Medical Competitors Cytosorbents Competitors Nexalin Technology Competitors CollPlant Biotechnologies Competitors Milestone Scientific Competitors Bellevue Life Sciences Acquisition Competitors Envoy Medical Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:AMIX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Autonomix Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Autonomix Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
